MedTrace Logo

Pulsed Electromagnetic Field on Chronic Anal Fissure Healing

NCT07729709 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-07-27

No results posted yet for this study

Summary

The purpose of this study is to find the effect of Pulsed Electromagnetic Field on chronic Anal fissure healing. Included both male and female aged 30-60 suffering from Anal fissure symptoms.

It aims to answer is:

There is no significant effect of Pulsed Electromagnetic Field on chronic Anal fissure healing.

There is a significant effect of Pulsed Electromagnetic Field on chronic Anal fissure healing.

Conditions

  • Anal Fissure Chronic

Interventions

DEVICE

PEMS, Lidocaine and general advice

PEMF 3 session per week- every session 30 minute for 4 weeks. The treatment session consists of 3 phases; first phase consists of 10 min with intensity 100%- frequency 1 Hz, second phase consist of 10 min with intensity 100%- frequency 1-50 Hz, third phase consist of 10 min with intensity 90% - frequency 50 Hz. in addition to Lidocaine cream use around anus twice daily and general advice for 4 weeks.

DRUG

Lidocaine cream and general advice

All patients begin medical treatment with Lidocaine cream twice daily around anus and received general advice with types of food taken to prevent constipation and increase fluid intake and not to beer down during micturition for 4 weeks.

Sponsors & Collaborators

  • Galala University

    lead OTHER

Principal Investigators

  • Marwa A Radwan, Ph.D. · Lecturer in Galala University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-03
Primary Completion
2026-05-22
Completion
2026-05-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07729709 on ClinicalTrials.gov